1. Home
  2. CRVL vs VERA Comparison

CRVL vs VERA Comparison

Compare CRVL & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorVel Corp.

CRVL

CorVel Corp.

HOLD

Current Price

$59.91

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$31.86

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVL
VERA
Founded
1987
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
CRVL
VERA
Price
$59.91
$31.86
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$81.30
AVG Volume (30 Days)
180.8K
1.0M
Earning Date
05-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
16.94
N/A
EPS
2.14
N/A
Revenue
$958,527,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$472.48
P/E Ratio
$27.67
N/A
Revenue Growth
7.03
N/A
52 Week Low
$44.83
$19.07
52 Week High
$111.27
$56.05

Technical Indicators

Market Signals
Indicator
CRVL
VERA
Relative Strength Index (RSI) 53.83 38.63
Support Level $55.68 $27.19
Resistance Level $71.89 $31.92
Average True Range (ATR) 3.00 2.24
MACD -0.30 -0.16
Stochastic Oscillator 53.17 18.76

Price Performance

Historical Comparison
CRVL
VERA

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: